Evaluating Efficient Bioburden Control From Drug-Linker to ADC Drug Substance

11:15 am - Tuesday 9th March 2027

  • Navigating a holistic and risk-based approach for both drug-linker and ADC drug substance process
  • Exploring a case study of environmental monitoring of drug linker and ADC drug substance facilities
  • Using case study examples to assess drug-linker and ADC microbial methods

Speakers:

Head of bioconjugation operations
Axplora